Peripheral Blood Single Cell Sequencing Analysis of POD and CPSP in Elderly Patients After Total Knee Arthroplasty
1 other identifier
observational
10
1 country
1
Brief Summary
Single-celled sequencing for evaluating differences in gene expression patterns in different cell types of the dynamics of a means of this research as a starting point, to study the postoperative delirium and chronic pain at the cellular level changes the contents of a cell, reveal its occurrence and development of the role of gene regulation, find targets and biomarkers, and to provide new ideas for its pathogenesis, To provide theoretical basis support for its prevention, clinical diagnosis and treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2022
CompletedFirst Posted
Study publicly available on registry
October 7, 2022
CompletedStudy Start
First participant enrolled
October 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedMarch 8, 2023
September 1, 2022
1 year
September 29, 2022
March 7, 2023
Conditions
Outcome Measures
Primary Outcomes (6)
Difference of single cell sequencing before and after surgery
Leukocytes were isolated from peripheral blood and then sorted for subsequent single-cell sequencing analysis. Unbiased, high-throughput and high-resolution transcriptome analysis of single cells can reveal the gene structure and gene expression status of single cells, reflect the heterogeneity between cells, classify and analyze them, and carry out personalized research
1 day before surgery,1 day after surgery
3-minute Diagnostic Interview for CAM (3D-CAM)
Postoperative delirium was assessed by 3-minute Diagnostic Interview for confusion assessment method (CAM).
Consecutive 7 days after the surgery
Visual analogue scale(VAS)
A moving scale measuring about 10cm in length was used, with 10 scales on one side and "0" and "10" ends, respectively, with 0 indicating no pain and 10 indicating the most severe pain that could not be endured.
3 months after the surgery
Short form McGill pain questionnaire(SF-MPQ)
SF-MPQ is composed of sensory and emotional descriptors of pain, current pain intensity and visual analogue scale.
3 months after the surgery
Leeds Assessment of Neuropathic Symptoms and Signs(LANSS)
Make the needle perpendicular to the patient's skin, and apply different pressure on the skin to determine whether the patient has touch-induced pain.
3 months after the surgery
Pain catastrophizing scale(PCS)
PCS is defined as a belief system, a coping strategy and an evaluation process when experiencing and feeling pain.
3 months after the surgery
Study Arms (4)
POD group
According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group
non-POD group
According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group
CPSP group
Patients were divided into CPSP group and non-CPSP group according to the occurrence of postoperative chronic pain
non-CSP group
Patients were divided into CPSP group and non-CPSP group according to the occurrence of postoperative chronic pain
Eligibility Criteria
Patients undergoing elective total knee replacement.
You may qualify if:
- Age ≥65 years old, regardless of gender.
- total knee arthroplasty for the first time.
- The ASA classification is I-Ⅲ.
You may not qualify if:
- severe neurological or psychiatric disorders
- drug and alcohol abuse
- patients on antidepressants
- failure and decompensation of vital organs
- chronic pain from previous surgery or trauma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Xuzhou Central Hospital
Xuzhou, Jiangsu, 221000, China
Biospecimen
Nucleated cells from peripheral blood were extracted and frozen.These cells are destroyed after single-cell sequencing.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yangzi Zhu, Doctor
Xuzhou Central Hospital
- STUDY DIRECTOR
Liwei Wang, Doctor
Xuzhou Central Hospital
- STUDY DIRECTOR
Junli Cao, Doctor
Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University
- STUDY CHAIR
Daqing Ma, Doctor
Imperial College London, Chelsea and Westminster Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2022
First Posted
October 7, 2022
Study Start
October 30, 2022
Primary Completion
October 30, 2023
Study Completion
December 31, 2023
Last Updated
March 8, 2023
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share